Zobrazeno 1 - 10
of 296
pro vyhledávání: '"J, Osterman"'
Publikováno v:
American Society of Clinical Oncology Educational Book.
Improving technology has promised to improved health care delivery and the lives of patients. The realized benefits of technology, however, are delayed or less than anticipated. Three recent technology initiatives are reviewed: the Clinical Trials Ra
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
JCO Clinical Cancer Informatics. :231-238
PURPOSE Tumor next-generation sequencing reports typically generate trial recommendations for patients based on their diagnosis and genomic profile. However, these require additional refinement and prescreening, which can add to physician burden. We
Autor:
Waddah Arafat, Daniel B Martin, Tricia Heinrichs, Fernanda Polubriaginof, Jessica Sugalski, Travis J. Osterman, Amye J. Tevaarwerk, Jeffrey B. Smerage, Thevaa Chandereng
Publikováno v:
JCO Oncol Pract
PURPOSE: The use of telemedicine expanded dramatically in March 2020 following the COVID-19 pandemic. We sought to assess oncologist perspectives on telemedicine's present and future roles (both phone and video) for patients with cancer. METHODS: The
Autor:
Wei-Qi Wei, Lisa A Bastarache, Robert J Carroll, Joy E Marlo, Travis J Osterman, Eric R Gamazon, Nancy J Cox, Dan M Roden, Joshua C Denny
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0175508 (2017)
To compare three groupings of Electronic Health Record (EHR) billing codes for their ability to represent clinically meaningful phenotypes and to replicate known genetic associations. The three tested coding systems were the International Classificat
Externí odkaz:
https://doaj.org/article/687557415a544a6f932061a9446b74ea
Autor:
Travis J. Osterman, Tricia Heinrichs, Daniel B Martin, Fernanda Polubriaginof, Waddah Arafat, Jessica Sugalski, Jeffrey B. Smerage, Amye J. Tevaarwerk
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:583-592
Introduction: The use of telemedicine in the oncology (Onc) setting expanded after March 2020 due to the COVID-19 pandemic. Patients and providers report satisfaction with telemedicine within the context of acute pandemic needs (Darcourt et al, JOP,
Publikováno v:
JCO Clin Cancer Inform
PURPOSE Because of expanding interoperability requirements, structured patient data are increasingly available in electronic health records. Many oncology data elements (eg, staging, biomarkers, documentation of adverse events and cancer outcomes) re
Publikováno v:
JCO Clinical Cancer Informatics
In this work, we present a conceptual framework to support clinical trial optimization and enrollment workflows and review the current state, limitations, and future trends in this space. This framework includes knowledge representation of clinical t
Autor:
Michele LeNoue-Newton, Kathleen F. Mittendorf, Ingrid A. Anderson, Marilyn E. Holt, Christine M. Micheel, Mia Levy, Neha Jain, Christine M. Lovly, Travis J. Osterman
Publikováno v:
JCO Clinical Cancer Informatics
PURPOSE The My Cancer Genome (MCG) knowledgebase and resulting website were launched in 2011 with the purpose of guiding clinicians in the application of genomic testing results for treatment of patients with cancer. Both knowledgebase and website we
Autor:
Nancy L. Keating, James L. Chen, Travis J. Osterman, Ramy Saleh, Eitan Amir, Danielle Rodin, David A. Chambers
Publikováno v:
American Society of Clinical Oncology Educational Book. :e167-e175
The concept of “big data” research—the aggregation and analysis of biologic, clinical, administrative, and other data sources to drive new advances in biomedical knowledge—has been embraced by the cancer research enterprise. Although much of